Showing results (2151-2160 of 2,269) with videos related to

Sort By:
Pageof 227
ESMO Gastrointestinal Oncology|February 6, 2026
Early bevacizumab dose and time modifications may affect efficacy of atezolizumab plus bevacizumab for advanced hepatocellular carcinoma treatmentF Rossari, D Lavacchi, E Alimenti, et al.
Frontiers in Behavioral Neuroscience|July 25, 2022
Toward Precision Medicine in ADHDJan Buitelaar, Sven Bölte, Daniel Brandeis, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 24, 2001
Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trialL L Greenhill, J M Swanson, B Vitiello, et al.
Journal of Consulting and Clinical Psychology|June 11, 2003
Which treatment for whom for ADHD? Moderators of treatment response in the MTAElizabeth B Owens, Stephen P Hinshaw, Helen C Kraemer, et al.
Journal of Neurosurgical Sciences|September 25, 2020
Degenerative Lumbar Spine Stenosis Consensus Conference: the Italian job. Recommendations of the Spinal Section of the Italian Society of NeurosurgeryFrancesco Costa, Gualtiero Innocenzi, Franco Guida, et al.
Frontiers in Medicine|September 19, 2022
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysisCristiano Caruso, Paolo Cameli, Elena Altieri, et al.
Nutrients|January 8, 2023
Development of the Italian Clinical Practice Guidelines on Bariatric and Metabolic Surgery: Design and Methodological AspectsMaurizio De Luca, Marco Antonio Zappa, Monica Zese, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 24, 2001
Multimodal treatment of ADHD in the MTA: an alternative outcome analysisC K Conners, J N Epstein, J S March, et al.
Journal of Abnormal Child Psychology|March 5, 2004
Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading proceduresL Eugene Arnold, Shirley Chuang, Mark Davies, et al.
Molecular Cancer Therapeutics|March 3, 2019
EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal CancerGiulia Martini, Claudia Cardone, Pietro Paolo Vitiello, et al.
Pageof 227